Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gene Expression Profiling | 49 | 2020 | 9438 | 2.390 |
Why?
|
Oligonucleotide Array Sequence Analysis | 43 | 2018 | 3920 | 2.040 |
Why?
|
Toxicogenetics | 12 | 2016 | 31 | 1.090 |
Why?
|
Acetaminophen | 6 | 2016 | 545 | 0.880 |
Why?
|
Cluster Analysis | 11 | 2016 | 2715 | 0.820 |
Why?
|
Genome, Mitochondrial | 1 | 2022 | 71 | 0.800 |
Why?
|
Computational Biology | 15 | 2020 | 3521 | 0.760 |
Why?
|
Organ Specificity | 4 | 2020 | 2008 | 0.730 |
Why?
|
Epistasis, Genetic | 1 | 2022 | 365 | 0.690 |
Why?
|
Databases, Genetic | 11 | 2018 | 1783 | 0.680 |
Why?
|
Sequence Analysis, RNA | 3 | 2016 | 2012 | 0.630 |
Why?
|
Analgesics, Non-Narcotic | 3 | 2016 | 365 | 0.610 |
Why?
|
Cell Nucleus | 3 | 2022 | 2969 | 0.520 |
Why?
|
Liver | 14 | 2018 | 7474 | 0.520 |
Why?
|
Pattern Recognition, Automated | 6 | 2009 | 1005 | 0.500 |
Why?
|
MicroRNAs | 3 | 2020 | 3752 | 0.490 |
Why?
|
Xenobiotics | 3 | 2010 | 73 | 0.480 |
Why?
|
Gene Expression | 15 | 2016 | 7799 | 0.470 |
Why?
|
Principal Component Analysis | 5 | 2016 | 940 | 0.430 |
Why?
|
Models, Genetic | 6 | 2016 | 3494 | 0.430 |
Why?
|
Poisson Distribution | 1 | 2013 | 513 | 0.410 |
Why?
|
3' Untranslated Regions | 1 | 2013 | 513 | 0.390 |
Why?
|
Mitochondria | 2 | 2022 | 3520 | 0.390 |
Why?
|
Gene Expression Regulation, Fungal | 2 | 2012 | 502 | 0.380 |
Why?
|
Algorithms | 14 | 2011 | 13881 | 0.370 |
Why?
|
Gene Expression Regulation | 19 | 2020 | 12072 | 0.360 |
Why?
|
Alanine Transaminase | 4 | 2016 | 592 | 0.360 |
Why?
|
Markov Chains | 1 | 2013 | 969 | 0.350 |
Why?
|
Chlorobenzenes | 1 | 2009 | 28 | 0.350 |
Why?
|
Rats | 23 | 2020 | 24260 | 0.340 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 15519 | 0.330 |
Why?
|
Blood | 3 | 2008 | 598 | 0.330 |
Why?
|
Proteome | 2 | 2009 | 1799 | 0.320 |
Why?
|
Poisons | 1 | 2008 | 34 | 0.310 |
Why?
|
Software | 3 | 2016 | 4443 | 0.310 |
Why?
|
Data Interpretation, Statistical | 3 | 2007 | 2716 | 0.300 |
Why?
|
Schizosaccharomyces | 1 | 2009 | 237 | 0.300 |
Why?
|
Database Management Systems | 3 | 2006 | 270 | 0.300 |
Why?
|
Fungal Proteins | 2 | 2009 | 912 | 0.290 |
Why?
|
Necrosis | 2 | 2008 | 1643 | 0.290 |
Why?
|
Clinical Chemistry Tests | 1 | 2007 | 61 | 0.290 |
Why?
|
RNA | 3 | 2016 | 2749 | 0.280 |
Why?
|
Gene Regulatory Networks | 5 | 2022 | 1708 | 0.260 |
Why?
|
Cell Cycle | 4 | 2011 | 2967 | 0.260 |
Why?
|
Pharmacogenetics | 4 | 2016 | 675 | 0.250 |
Why?
|
Signal Transduction | 14 | 2022 | 23403 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2022 | 8428 | 0.250 |
Why?
|
Transcription, Genetic | 11 | 2019 | 7722 | 0.240 |
Why?
|
Biological Assay | 1 | 2007 | 652 | 0.240 |
Why?
|
DNA Methylation | 4 | 2019 | 4286 | 0.240 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 2019 | 0.240 |
Why?
|
Promoter Regions, Genetic | 13 | 2019 | 5867 | 0.240 |
Why?
|
RNA, Messenger | 14 | 2019 | 13033 | 0.230 |
Why?
|
Cell Cycle Proteins | 4 | 2009 | 3462 | 0.230 |
Why?
|
Genomics | 7 | 2022 | 5720 | 0.220 |
Why?
|
Leiomyoma | 2 | 2022 | 730 | 0.220 |
Why?
|
Epigenesis, Genetic | 4 | 2019 | 3647 | 0.210 |
Why?
|
Seed Storage Proteins | 1 | 2022 | 12 | 0.210 |
Why?
|
Polybrominated Biphenyls | 1 | 2022 | 28 | 0.210 |
Why?
|
Ozone | 2 | 2016 | 469 | 0.210 |
Why?
|
Antigens, Plant | 1 | 2022 | 86 | 0.200 |
Why?
|
Genetic Variation | 7 | 2021 | 6544 | 0.200 |
Why?
|
Animals | 44 | 2022 | 168757 | 0.200 |
Why?
|
Juglans | 1 | 2022 | 43 | 0.200 |
Why?
|
Sequence Analysis, DNA | 3 | 2021 | 4803 | 0.200 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2018 | 2948 | 0.200 |
Why?
|
Biological Phenomena | 1 | 2020 | 28 | 0.190 |
Why?
|
Rodentia | 1 | 2022 | 261 | 0.190 |
Why?
|
Introns | 2 | 2022 | 991 | 0.190 |
Why?
|
Artificial Intelligence | 3 | 2010 | 2214 | 0.180 |
Why?
|
Alleles | 2 | 2022 | 6933 | 0.180 |
Why?
|
Models, Biological | 6 | 2012 | 9583 | 0.180 |
Why?
|
DNA Damage | 7 | 2016 | 2432 | 0.180 |
Why?
|
Breast Neoplasms | 7 | 2022 | 20822 | 0.180 |
Why?
|
Leupeptins | 1 | 2019 | 122 | 0.180 |
Why?
|
Radiation, Ionizing | 4 | 2013 | 258 | 0.180 |
Why?
|
Cell Size | 1 | 2022 | 643 | 0.180 |
Why?
|
User-Computer Interface | 2 | 2007 | 1431 | 0.180 |
Why?
|
Genes, ras | 4 | 1995 | 690 | 0.170 |
Why?
|
Ataxia Telangiectasia | 2 | 2013 | 112 | 0.170 |
Why?
|
Uterus | 2 | 2015 | 711 | 0.170 |
Why?
|
Rats, Inbred F344 | 3 | 2009 | 862 | 0.170 |
Why?
|
Cyclic N-Oxides | 1 | 2018 | 78 | 0.160 |
Why?
|
Pregnancy, Animal | 1 | 2019 | 134 | 0.160 |
Why?
|
Genetic Testing | 2 | 2021 | 3444 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11524 | 0.160 |
Why?
|
Models, Statistical | 4 | 2009 | 5102 | 0.150 |
Why?
|
Sequence Alignment | 1 | 2002 | 2256 | 0.150 |
Why?
|
RNA Polymerase II | 2 | 2019 | 551 | 0.150 |
Why?
|
Homozygote | 1 | 2022 | 1785 | 0.150 |
Why?
|
Genome | 4 | 2018 | 1808 | 0.150 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 553 | 0.150 |
Why?
|
Citric Acid Cycle | 1 | 2018 | 232 | 0.150 |
Why?
|
Mitogens | 1 | 2017 | 232 | 0.150 |
Why?
|
Cell Communication | 2 | 2022 | 1621 | 0.140 |
Why?
|
Actins | 5 | 1995 | 2121 | 0.140 |
Why?
|
Oncogenes | 2 | 2021 | 1265 | 0.140 |
Why?
|
NF-kappa B | 4 | 2014 | 2499 | 0.140 |
Why?
|
DNA-Binding Proteins | 7 | 2018 | 9648 | 0.140 |
Why?
|
X Chromosome Inactivation | 1 | 2018 | 224 | 0.140 |
Why?
|
Fibroblasts | 6 | 2007 | 4161 | 0.140 |
Why?
|
Ileum | 1 | 2018 | 565 | 0.140 |
Why?
|
Toxicology | 2 | 2010 | 106 | 0.140 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2015 | 33 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3597 | 0.130 |
Why?
|
Quality Control | 4 | 2010 | 841 | 0.130 |
Why?
|
Methionine | 1 | 2018 | 590 | 0.130 |
Why?
|
Neoplasms | 7 | 2022 | 21683 | 0.130 |
Why?
|
Mannose-Binding Lectin | 1 | 2016 | 150 | 0.130 |
Why?
|
Apoptosis | 3 | 2011 | 9727 | 0.130 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2016 | 514 | 0.130 |
Why?
|
Fibrosis | 1 | 2022 | 2029 | 0.130 |
Why?
|
Allergens | 1 | 2022 | 1320 | 0.120 |
Why?
|
Chromatin | 2 | 2019 | 2934 | 0.120 |
Why?
|
NAD | 1 | 2018 | 593 | 0.120 |
Why?
|
Gene Frequency | 1 | 2021 | 3588 | 0.120 |
Why?
|
High-Throughput Screening Assays | 2 | 2018 | 944 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 2007 | 0.120 |
Why?
|
Humans | 62 | 2022 | 744343 | 0.120 |
Why?
|
Pneumonia | 2 | 2016 | 2133 | 0.120 |
Why?
|
Saccharomyces cerevisiae | 4 | 2012 | 2752 | 0.110 |
Why?
|
Single-Blind Method | 2 | 2016 | 1590 | 0.110 |
Why?
|
RNA Interference | 2 | 2020 | 2889 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 7 | 2018 | 8301 | 0.110 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1338 | 0.110 |
Why?
|
Carcinogens | 3 | 2022 | 466 | 0.110 |
Why?
|
Phenotype | 9 | 2018 | 16365 | 0.110 |
Why?
|
Peroxisome Proliferators | 2 | 2002 | 8 | 0.110 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 817 | 0.110 |
Why?
|
Administration, Oral | 3 | 2016 | 3913 | 0.110 |
Why?
|
Benchmarking | 1 | 2019 | 1042 | 0.110 |
Why?
|
Information Storage and Retrieval | 3 | 2007 | 824 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1513 | 0.110 |
Why?
|
Globins | 2 | 1990 | 415 | 0.110 |
Why?
|
Gamma Rays | 2 | 2003 | 320 | 0.100 |
Why?
|
G1 Phase | 4 | 2006 | 415 | 0.100 |
Why?
|
Ribonucleases | 1 | 2012 | 287 | 0.100 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.100 |
Why?
|
Endocrine Disruptors | 1 | 2015 | 237 | 0.100 |
Why?
|
Microarray Analysis | 2 | 2014 | 767 | 0.100 |
Why?
|
Phenobarbital | 2 | 2002 | 193 | 0.100 |
Why?
|
Genes | 2 | 2018 | 1893 | 0.100 |
Why?
|
Air Pollutants | 2 | 2016 | 2817 | 0.100 |
Why?
|
Gammaproteobacteria | 1 | 2010 | 29 | 0.100 |
Why?
|
Carbon Tetrachloride Poisoning | 1 | 2010 | 13 | 0.100 |
Why?
|
Propanols | 1 | 2010 | 10 | 0.100 |
Why?
|
Tobacco Smoke Pollution | 1 | 2017 | 816 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4933 | 0.100 |
Why?
|
Muscle, Smooth | 5 | 1995 | 934 | 0.090 |
Why?
|
DNA | 3 | 2016 | 7301 | 0.090 |
Why?
|
Predictive Value of Tests | 7 | 2016 | 15076 | 0.090 |
Why?
|
Response Elements | 1 | 2012 | 312 | 0.090 |
Why?
|
Bifidobacterium | 1 | 2010 | 100 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2015 | 739 | 0.090 |
Why?
|
Pneumonia, Bacterial | 1 | 2013 | 316 | 0.090 |
Why?
|
CpG Islands | 3 | 2019 | 1172 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 9 | 2012 | 4751 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2015 | 1117 | 0.090 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2011 | 96 | 0.090 |
Why?
|
Female | 22 | 2022 | 380194 | 0.090 |
Why?
|
Drug Monitoring | 1 | 2016 | 956 | 0.090 |
Why?
|
Toxicity Tests | 2 | 2007 | 121 | 0.090 |
Why?
|
Estrogen Receptor alpha | 2 | 2012 | 577 | 0.090 |
Why?
|
Pancreas | 1 | 2016 | 1686 | 0.090 |
Why?
|
Proteomics | 5 | 2011 | 3638 | 0.090 |
Why?
|
False Positive Reactions | 1 | 2012 | 981 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1736 | 0.090 |
Why?
|
Medical Oncology | 1 | 2021 | 2265 | 0.080 |
Why?
|
Erythroid Precursor Cells | 1 | 1990 | 218 | 0.080 |
Why?
|
Genome, Fungal | 2 | 2008 | 204 | 0.080 |
Why?
|
Liver Function Tests | 1 | 2010 | 528 | 0.080 |
Why?
|
Demography | 1 | 2013 | 1656 | 0.080 |
Why?
|
Transition Elements | 1 | 2008 | 18 | 0.080 |
Why?
|
DNA Repair | 2 | 2012 | 2046 | 0.080 |
Why?
|
Ultraviolet Rays | 2 | 2003 | 1060 | 0.080 |
Why?
|
L-Iditol 2-Dehydrogenase | 1 | 2007 | 5 | 0.080 |
Why?
|
Carcinogenicity Tests | 2 | 2022 | 41 | 0.080 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2012 | 1888 | 0.080 |
Why?
|
Reproducibility of Results | 7 | 2021 | 19905 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1790 | 0.080 |
Why?
|
Cell Line | 12 | 2020 | 15997 | 0.080 |
Why?
|
Leukocyte Count | 2 | 2013 | 1588 | 0.080 |
Why?
|
Environmental Pollutants | 2 | 2015 | 1179 | 0.080 |
Why?
|
Internet | 2 | 2018 | 3064 | 0.080 |
Why?
|
Male | 23 | 2020 | 350118 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 1995 | 2942 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 3 | 2007 | 2849 | 0.080 |
Why?
|
Metagenome | 1 | 2010 | 418 | 0.070 |
Why?
|
Immunity, Innate | 2 | 2016 | 2958 | 0.070 |
Why?
|
DNA, Complementary | 7 | 2004 | 2050 | 0.070 |
Why?
|
Cell Death | 2 | 2013 | 1706 | 0.070 |
Why?
|
Phosphorylation | 5 | 2022 | 8436 | 0.070 |
Why?
|
Biomedical Research | 2 | 2016 | 3309 | 0.070 |
Why?
|
Transcription Initiation Site | 2 | 2019 | 196 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1903 | 0.070 |
Why?
|
Base Sequence | 7 | 2015 | 12797 | 0.070 |
Why?
|
Software Design | 1 | 2006 | 176 | 0.070 |
Why?
|
Data Display | 2 | 2007 | 182 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4420 | 0.060 |
Why?
|
Inflammation | 3 | 2017 | 10638 | 0.060 |
Why?
|
Programming Languages | 2 | 2006 | 133 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2899 | 0.060 |
Why?
|
Mice | 13 | 2018 | 81183 | 0.060 |
Why?
|
Lymphocytes | 2 | 2018 | 2617 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4665 | 0.060 |
Why?
|
Feces | 1 | 2010 | 1401 | 0.060 |
Why?
|
Gastrointestinal Tract | 1 | 2010 | 814 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1477 | 0.060 |
Why?
|
Cell Lineage | 1 | 2013 | 2504 | 0.060 |
Why?
|
Estrogens | 3 | 2022 | 1566 | 0.060 |
Why?
|
Computer Simulation | 2 | 2009 | 6196 | 0.060 |
Why?
|
Public Health | 1 | 2016 | 2603 | 0.060 |
Why?
|
Computer Graphics | 1 | 2005 | 361 | 0.060 |
Why?
|
Lung | 3 | 2017 | 9856 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2012 | 4740 | 0.060 |
Why?
|
Radiation Tolerance | 1 | 2006 | 486 | 0.060 |
Why?
|
Furans | 1 | 2004 | 194 | 0.060 |
Why?
|
Methapyrilene | 1 | 2002 | 1 | 0.060 |
Why?
|
Protein Biosynthesis | 2 | 2018 | 2126 | 0.050 |
Why?
|
Genes, cdc | 1 | 2003 | 116 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2019 | 10943 | 0.050 |
Why?
|
DNA Copy Number Variations | 2 | 2021 | 1941 | 0.050 |
Why?
|
Calibration | 1 | 2005 | 816 | 0.050 |
Why?
|
Macrophages | 2 | 2014 | 5655 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4554 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2016 | 4234 | 0.050 |
Why?
|
Metabolomics | 1 | 2011 | 1484 | 0.050 |
Why?
|
Histamine H1 Antagonists | 1 | 2002 | 100 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2003 | 3086 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6459 | 0.050 |
Why?
|
Mutagens | 1 | 2002 | 168 | 0.050 |
Why?
|
Liver Diseases | 1 | 2010 | 1253 | 0.050 |
Why?
|
Cardiac Output, Low | 1 | 2002 | 195 | 0.050 |
Why?
|
Systems Biology | 1 | 2005 | 469 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2703 | 0.050 |
Why?
|
Species Specificity | 2 | 2019 | 2478 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2002 | 5853 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2019 | 21827 | 0.050 |
Why?
|
DNA Replication | 2 | 2012 | 1399 | 0.050 |
Why?
|
Knowledge | 1 | 2003 | 181 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2018 | 14557 | 0.050 |
Why?
|
Base Pair Mismatch | 1 | 2001 | 97 | 0.050 |
Why?
|
Terminology as Topic | 2 | 2005 | 1547 | 0.050 |
Why?
|
Ovariectomy | 2 | 2015 | 661 | 0.050 |
Why?
|
Molecular Sequence Data | 6 | 2002 | 18111 | 0.050 |
Why?
|
Databases as Topic | 1 | 2003 | 475 | 0.050 |
Why?
|
Estradiol | 2 | 2012 | 2020 | 0.050 |
Why?
|
Limit of Detection | 1 | 2021 | 265 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2008 | 2309 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17446 | 0.050 |
Why?
|
Lung Diseases | 1 | 2010 | 1886 | 0.040 |
Why?
|
Cross Reactions | 1 | 2022 | 841 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 3 | 2007 | 876 | 0.040 |
Why?
|
Benzo(a)pyrene | 1 | 2019 | 26 | 0.040 |
Why?
|
Aflatoxin B1 | 1 | 2019 | 18 | 0.040 |
Why?
|
Disease Susceptibility | 2 | 2018 | 1782 | 0.040 |
Why?
|
Time Factors | 4 | 2016 | 40075 | 0.040 |
Why?
|
Computer Communication Networks | 1 | 2001 | 295 | 0.040 |
Why?
|
Gene Deletion | 3 | 2013 | 2751 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 16689 | 0.040 |
Why?
|
Environmental Health | 1 | 2001 | 278 | 0.040 |
Why?
|
Genome-Wide Association Study | 3 | 2013 | 12261 | 0.040 |
Why?
|
Mice, Inbred Strains | 2 | 2012 | 1827 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2214 | 0.040 |
Why?
|
Databases, Factual | 2 | 2005 | 7729 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2018 | 2216 | 0.040 |
Why?
|
Tricarboxylic Acids | 1 | 2018 | 29 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 2011 | 4253 | 0.040 |
Why?
|
Tamoxifen | 1 | 2003 | 981 | 0.040 |
Why?
|
DNA, Intergenic | 1 | 2018 | 107 | 0.040 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1990 | 798 | 0.040 |
Why?
|
Genes, Fungal | 3 | 2008 | 455 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14722 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2017 | 3690 | 0.040 |
Why?
|
DNA Primers | 3 | 2001 | 2892 | 0.040 |
Why?
|
Up-Regulation | 3 | 2016 | 4217 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 2019 | 964 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
Genotype | 1 | 2012 | 12951 | 0.040 |
Why?
|
Epithelium | 1 | 2002 | 1679 | 0.040 |
Why?
|
Nitric Oxide | 2 | 2018 | 2132 | 0.040 |
Why?
|
Acetylation | 1 | 2019 | 1085 | 0.040 |
Why?
|
Spin Labels | 1 | 2018 | 332 | 0.040 |
Why?
|
Workflow | 1 | 2021 | 847 | 0.030 |
Why?
|
Connexin 43 | 1 | 2017 | 207 | 0.030 |
Why?
|
Interferon-beta | 1 | 2018 | 323 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 602 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2002 | 851 | 0.030 |
Why?
|
Nucleosomes | 1 | 2019 | 494 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2022 | 1463 | 0.030 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2015 | 61 | 0.030 |
Why?
|
Gap Junctions | 1 | 2017 | 233 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2017 | 3701 | 0.030 |
Why?
|
Diarylheptanoids | 1 | 2015 | 3 | 0.030 |
Why?
|
Terminal Repeat Sequences | 1 | 2015 | 72 | 0.030 |
Why?
|
Gluconeogenesis | 1 | 2016 | 183 | 0.030 |
Why?
|
Binding Sites | 2 | 2016 | 6114 | 0.030 |
Why?
|
Discriminant Analysis | 2 | 2008 | 235 | 0.030 |
Why?
|
Restriction Mapping | 3 | 1990 | 878 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2016 | 386 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2019 | 635 | 0.030 |
Why?
|
Glomerular Mesangium | 1 | 1995 | 108 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2011 | 18029 | 0.030 |
Why?
|
Serum Response Factor | 1 | 1995 | 81 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2018 | 809 | 0.030 |
Why?
|
Phytoestrogens | 1 | 2015 | 61 | 0.030 |
Why?
|
Risk Assessment | 2 | 2015 | 23338 | 0.030 |
Why?
|
Asthma | 1 | 2013 | 6011 | 0.030 |
Why?
|
X Chromosome | 1 | 2018 | 814 | 0.030 |
Why?
|
G2 Phase | 2 | 2006 | 139 | 0.030 |
Why?
|
Research Design | 3 | 2005 | 5987 | 0.030 |
Why?
|
Serine | 1 | 2018 | 826 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 2015 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2022 | 1741 | 0.030 |
Why?
|
Genes, Regulator | 1 | 1995 | 378 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 474 | 0.030 |
Why?
|
Heart Diseases | 1 | 2007 | 2788 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5221 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2002 | 4186 | 0.030 |
Why?
|
Histones | 2 | 2019 | 2599 | 0.030 |
Why?
|
Reference Standards | 2 | 2010 | 1025 | 0.030 |
Why?
|
Genes, rRNA | 1 | 2012 | 70 | 0.030 |
Why?
|
Cyclin E | 2 | 2003 | 172 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2015 | 768 | 0.030 |
Why?
|
Multigene Family | 2 | 2008 | 1102 | 0.030 |
Why?
|
Ecosystem | 1 | 2016 | 474 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2187 | 0.030 |
Why?
|
Base Composition | 1 | 2012 | 293 | 0.030 |
Why?
|
Genetic Markers | 2 | 2016 | 2634 | 0.030 |
Why?
|
Hepatocytes | 1 | 2019 | 1211 | 0.030 |
Why?
|
Osteoblasts | 1 | 2018 | 1166 | 0.030 |
Why?
|
Myometrium | 1 | 2013 | 181 | 0.030 |
Why?
|
Cyclic AMP | 1 | 2016 | 1472 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 56430 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2002 | 5078 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2016 | 2327 | 0.030 |
Why?
|
S Phase | 2 | 2003 | 423 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2915 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1285 | 0.030 |
Why?
|
RNA, Fungal | 1 | 2012 | 164 | 0.030 |
Why?
|
Brain | 1 | 2018 | 26385 | 0.030 |
Why?
|
Spleen | 1 | 2018 | 2362 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2635 | 0.030 |
Why?
|
Dogs | 1 | 2016 | 3912 | 0.020 |
Why?
|
DNA, Fungal | 1 | 2012 | 280 | 0.020 |
Why?
|
Klebsiella pneumoniae | 1 | 2013 | 251 | 0.020 |
Why?
|
Folic Acid | 1 | 2018 | 1300 | 0.020 |
Why?
|
Mutation | 3 | 2021 | 29786 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2014 | 690 | 0.020 |
Why?
|
Cells, Cultured | 5 | 2007 | 19229 | 0.020 |
Why?
|
Carcinoma | 1 | 2002 | 2375 | 0.020 |
Why?
|
Th2 Cells | 1 | 2016 | 1061 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 390 | 0.020 |
Why?
|
Adolescent | 2 | 2016 | 85781 | 0.020 |
Why?
|
Sequence Deletion | 1 | 1995 | 1526 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1730 | 0.020 |
Why?
|
Down-Regulation | 2 | 2011 | 3002 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 698 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 2513 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1992 | 730 | 0.020 |
Why?
|
RNA, Transfer | 1 | 2012 | 316 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1152 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4409 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 592 | 0.020 |
Why?
|
Norway | 1 | 2010 | 448 | 0.020 |
Why?
|
Blotting, Western | 2 | 2011 | 5179 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2012 | 13102 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1990 | 803 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 1990 | 794 | 0.020 |
Why?
|
Transfection | 4 | 2007 | 5892 | 0.020 |
Why?
|
DNA Probes | 1 | 2010 | 560 | 0.020 |
Why?
|
Deoxyribonuclease I | 1 | 1990 | 229 | 0.020 |
Why?
|
Ribosomes | 1 | 2012 | 500 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2012 | 893 | 0.020 |
Why?
|
Premenopause | 1 | 2013 | 1033 | 0.020 |
Why?
|
Reference Values | 2 | 2008 | 4982 | 0.020 |
Why?
|
Survival Analysis | 2 | 2013 | 10252 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4204 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13815 | 0.020 |
Why?
|
Adult | 5 | 2016 | 214055 | 0.020 |
Why?
|
Genomic Instability | 1 | 2012 | 695 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1607 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4420 | 0.020 |
Why?
|
Retroviridae | 1 | 1990 | 914 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1206 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1915 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2010 | 572 | 0.020 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 211 | 0.020 |
Why?
|
Transcription Factors | 3 | 2016 | 12208 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2010 | 954 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2020 | 11483 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2013 | 1783 | 0.020 |
Why?
|
Heterozygote | 1 | 2013 | 2804 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2003 | 13695 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1097 | 0.020 |
Why?
|
Telomere | 1 | 2012 | 910 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2002 | 3129 | 0.020 |
Why?
|
Diploidy | 1 | 2006 | 138 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2022 | 10481 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3505 | 0.020 |
Why?
|
Erythropoiesis | 1 | 1990 | 705 | 0.020 |
Why?
|
Systems Integration | 1 | 2007 | 440 | 0.020 |
Why?
|
Middle Aged | 3 | 2016 | 213383 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1465 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2013 | 972 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2012 | 1341 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2012 | 1403 | 0.020 |
Why?
|
Cell Division | 2 | 2003 | 4568 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
Ligands | 1 | 2012 | 3282 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6314 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2008 | 1901 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2014 | 3200 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9386 | 0.010 |
Why?
|
tert-Butylhydroperoxide | 1 | 2003 | 10 | 0.010 |
Why?
|
Repressor Proteins | 1 | 1995 | 3023 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1995 | 222 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1405 | 0.010 |
Why?
|
Piperazines | 1 | 2014 | 2488 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 255 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1995 | 708 | 0.010 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2002 | 49 | 0.010 |
Why?
|
Hexobarbital | 1 | 2002 | 4 | 0.010 |
Why?
|
Clofibrate | 1 | 2002 | 5 | 0.010 |
Why?
|
Gemfibrozil | 1 | 2002 | 30 | 0.010 |
Why?
|
bcl-Associated Death Protein | 1 | 2002 | 107 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2010 | 1226 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2007 | 1344 | 0.010 |
Why?
|
Telomerase | 1 | 2007 | 730 | 0.010 |
Why?
|
Fasting | 1 | 2008 | 1593 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12026 | 0.010 |
Why?
|
Diethylhexyl Phthalate | 1 | 2002 | 81 | 0.010 |
Why?
|
Phenytoin | 1 | 2002 | 197 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2002 | 216 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 2002 | 270 | 0.010 |
Why?
|
Estrogen Receptor beta | 1 | 2002 | 175 | 0.010 |
Why?
|
Laboratories | 1 | 2005 | 463 | 0.010 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2002 | 336 | 0.010 |
Why?
|
Protein Array Analysis | 1 | 2003 | 411 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5217 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 2001 | 196 | 0.010 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2002 | 209 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 772 | 0.010 |
Why?
|
Protein Structure, Quaternary | 1 | 2001 | 436 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2003 | 671 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3703 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 694 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2002 | 927 | 0.010 |
Why?
|
Dimerization | 1 | 2001 | 893 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2002 | 780 | 0.010 |
Why?
|
Lymphokines | 1 | 2002 | 949 | 0.010 |
Why?
|
Carrier Proteins | 2 | 2002 | 5021 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7322 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2008 | 2585 | 0.010 |
Why?
|
Data Collection | 1 | 2007 | 3341 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11366 | 0.010 |
Why?
|
International Cooperation | 1 | 2004 | 1420 | 0.010 |
Why?
|
Organ Size | 1 | 2002 | 2252 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29144 | 0.010 |
Why?
|
Immune System | 1 | 2002 | 805 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2839 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2002 | 2649 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18370 | 0.010 |
Why?
|
Nocodazole | 1 | 1995 | 97 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2003 | 1526 | 0.010 |
Why?
|
Ethanol | 1 | 2002 | 1342 | 0.010 |
Why?
|
Disease Progression | 2 | 2002 | 13284 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 1995 | 290 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1995 | 377 | 0.010 |
Why?
|
Endothelins | 1 | 1995 | 138 | 0.010 |
Why?
|
Colchicine | 1 | 1995 | 243 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1917 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 13989 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12245 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 898 | 0.010 |
Why?
|
Gene Silencing | 1 | 2001 | 1538 | 0.010 |
Why?
|
Medical Informatics | 1 | 2001 | 745 | 0.010 |
Why?
|
Vinblastine | 1 | 1995 | 502 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2001 | 931 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2187 | 0.010 |
Why?
|
Vincristine | 1 | 1995 | 1039 | 0.010 |
Why?
|
Kidney | 1 | 2008 | 7186 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2010 | 5181 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1993 | 286 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 5882 | 0.010 |
Why?
|
Xenopus laevis | 1 | 1995 | 957 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4669 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3768 | 0.010 |
Why?
|
Terminator Regions, Genetic | 1 | 1990 | 28 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3508 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 25625 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2001 | 2916 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1990 | 189 | 0.010 |
Why?
|
Pyrimidines | 1 | 2002 | 2942 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2001 | 4328 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72290 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1990 | 476 | 0.010 |
Why?
|
Calcium | 1 | 2002 | 5756 | 0.010 |
Why?
|
Paclitaxel | 1 | 1995 | 1708 | 0.000 |
Why?
|
Cohort Studies | 1 | 2010 | 40561 | 0.000 |
Why?
|
Proteins | 1 | 2002 | 6103 | 0.000 |
Why?
|
RNA Splicing | 1 | 1990 | 907 | 0.000 |
Why?
|
Child | 1 | 2013 | 77709 | 0.000 |
Why?
|
Exons | 1 | 1990 | 2437 | 0.000 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1990 | 2245 | 0.000 |
Why?
|
United States | 1 | 2002 | 69872 | 0.000 |
Why?
|
Aged | 1 | 2002 | 163280 | 0.000 |
Why?
|